Article info

Download PDFPDF
In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent
  1. Dr Anna Fogdell-Hahn, PhD, Karolinska Institutet, Department of Clinical Neuroscience, Division of Neurology R54, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden; Anna.Fogdell-Hahn{at}ki.se
View Full Text

Citation

Sominanda A, Hillert J, Fogdell-Hahn A
In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent

Publication history

  • Received April 12, 2007
  • Revised September 10, 2007
  • Accepted September 13, 2007
  • First published October 2, 2007.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.